Package 55154-6932-8

Brand: farxiga

Generic: dapagliflozin
NDC Package

Package Facts

Identity

Package NDC 55154-6932-8
Digits Only 5515469328
Product NDC 55154-6932
Product ID 55154-6932_38e8882e-539a-43cd-a916-48c69b8ac782
Description

1440 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6932-8)

Marketing

Marketing Status
Discontinued 2026-03-31
Brand farxiga
Generic dapagliflozin
Sample Package No

Linked Drug Pages (1)

FARXIGA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "38e8882e-539a-43cd-a916-48c69b8ac782", "openfda": {"upc": ["0303106210305", "0355154693289"], "unii": ["887K2391VH"], "rxcui": ["1486977", "1486981", "1488569", "1488574"], "spl_set_id": ["40cc4f5d-bcf6-4016-9d1e-838bbc4bdddc"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1440 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6932-8)", "package_ndc": "55154-6932-8", "marketing_end_date": "20260331", "marketing_start_date": "20150202"}], "brand_name": "FARXIGA", "product_id": "55154-6932_38e8882e-539a-43cd-a916-48c69b8ac782", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "55154-6932", "generic_name": "DAPAGLIFLOZIN", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FARXIGA", "active_ingredients": [{"name": "DAPAGLIFLOZIN PROPANEDIOL", "strength": "5 mg/1"}], "application_number": "NDA202293", "marketing_category": "NDA", "marketing_end_date": "20260331", "marketing_start_date": "20080114"}